Tue, Oct 21, 2014, 1:31 AM EDT - U.S. Markets open in 7 hrs 59 mins

Recent

% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

  • myprimitivesistas myprimitivesistas Nov 15, 2013 7:22 AM Flag

    Another layoff coming.

     

    That's the word from scientist friends I have inside the labs. I'm not sure if that will bump up the stock or bump it down. I don't care. I just have had a scientific relationship with this company for 15 years. used to own stock at $7 a long time ago. good luck. I am still finding jobs for scientists and salespeople that got laid off.

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Leiden might be incompetent....but not that incompetent that he has to do another layoff already! Joking aside, the board Need to start asking tough questions. cf was in place long before he got there so he's riding those coat tails. His proclamations around flu, RA and HCV.....plus promised other therapies have gone nowhere. Also heard he is building an ivory tower in their new headquarters......vertex has lost it's humility. Spending like sailors in port while the ship sinks.

      • 2 Replies to bootpart
      • Previous CEO spent 350 M for Virochem followed by wasting money on the development of VCH 222, VCH 759 and many others. VRTX 765 for seizure was a joke. Also he owns over 200, 000 shares as stock options of VRTX ($63 X 200, 000), for doing what?. Incivek is a failure and net loss. Current CEO is same way with over 193, 000 shares option reward. He was advertised as Adalimumab developer from ABT and he is openly resisting VX 509 development. They wasted time and money on VX 702 for oral rheumatoid drug development. CF program is not VRTX discovery, it was Aroura Bioscience which VRTX bought out for 500 Millions ( Wall Street money) in 2003. There is a u tube video where the company founder says that we are doing VRTX share offering not that we need to raise funds, people want to give us their money. I doubt VX 809 phase III will be as strong as phase II. If FEV 1 target is missed, this stock will be burn to death. I love it when stock is down, because it makes insiders not to gain from their poor job performances.

      • I do not know about the ivory tower. Maybe people in the know can comment. However, so far I am not very impressed with his performance at all. In a particular I think he erred greatly by allowing Alios go on with the 400mg of 135. Some may say that was Alios' s decision. I can not buy that. If VRTX was collaborating with Alios in that trial he should have set his foot down and not gone along allowing Alios to push the envelop to the extreme (400 mg)causing delays in the US trials.

 
VRTX
104.77+2.42(+2.36%)Oct 20 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.